Roberto Vargas: Clinical Trials

1 trial sponsored by Roberto Vargas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1

Follow Roberto Vargas: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
18F-Clofarabine - Metastatic Cancer, Carcinoma
Early Phase 1TerminatedRoberto Vargas52023-03-062026-08-07

Conditions studied

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)

Countries

United States (1)